Abstract Parkinsons disease (PD) is a chronic, progressive neurological disorder primarily affecting motor control, clinically characterized by resting tremor, bradykinesia, rigidity, and other symptoms that significantly diminish the quality of life
Safety Measurements Any adverse event during the course of the study was monitored and reported to the study staff at week 6 (visit 5) or week 12 (visit 8) in the clinic or directly to the principal investigator throughout the study
In recent years, semaglutide has emerged as a powerful tool in the fight against obesity and type 2 diabetes
Enzymes in the bloodstream degrade it within minutes of release, limiting its therapeutic potential
Therefore, assuming Reta passes, here's an approximate timeline and processes that must occur before it's available to the public